Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 27;115(48):12259-12264.
doi: 10.1073/pnas.1811129115. Epub 2018 Nov 14.

Aberrant IP3 receptor activities revealed by comprehensive analysis of pathological mutations causing spinocerebellar ataxia 29

Affiliations

Aberrant IP3 receptor activities revealed by comprehensive analysis of pathological mutations causing spinocerebellar ataxia 29

Hideaki Ando et al. Proc Natl Acad Sci U S A. .

Abstract

Spinocerebellar ataxia type 29 (SCA29) is autosomal dominant congenital ataxia characterized by early-onset motor delay, hypotonia, and gait ataxia. Recently, heterozygous missense mutations in an intracellular Ca2+ channel, inositol 1,4,5-trisphosphate (IP3) receptor type 1 (IP3R1), were identified as a cause of SCA29. However, the functional impacts of these mutations remain largely unknown. Here, we determined the molecular mechanisms by which pathological mutations affect IP3R1 activity and Ca2+ dynamics. Ca2+ imaging using IP3R-null HeLa cells generated by genome editing revealed that all SCA29 mutations identified within or near the IP3-binding domain of IP3R1 completely abolished channel activity. Among these mutations, R241K, T267M, T267R, R269G, R269W, S277I, K279E, A280D, and E497K impaired IP3 binding to IP3R1, whereas the T579I and N587D mutations disrupted channel activity without affecting IP3 binding, suggesting that T579I and N587D compromise channel gating mechanisms. Carbonic anhydrase-related protein VIII (CA8) is an IP3R1-regulating protein abundantly expressed in cerebellar Purkinje cells and is a causative gene of congenital ataxia. The SCA29 mutation V1538M within the CA8-binding site of IP3R1 completely eliminated its interaction with CA8 and CA8-mediated IP3R1 inhibition. Furthermore, pathological mutations in CA8 decreased CA8-mediated suppression of IP3R1 by reducing protein stability and the interaction with IP3R1. These results demonstrated the mechanisms by which pathological mutations cause IP3R1 dysfunction, i.e., the disruption of IP3 binding, IP3-mediated gating, and regulation via the IP3R-modulatory protein. The resulting aberrant Ca2+ homeostasis may contribute to the pathogenesis of cerebellar ataxia.

Keywords: IP3 receptor; calcium signaling; carbonic anhydrase-related protein VIII; missense mutation; spinocerebellar ataxia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
IP3R triple knockout HeLa cells and IP3R1 mutants. (A) Western blotting of IP3R single, double, or triple knockout HeLa cells. (B and C) Ca2+ imaging. Wild-type or TKO HeLa cells were loaded with Fura-2 AM and stimulated with 10 μM histamine (B) or 1 μM thapsigargin (C). Representative traces of the Fura-2 fluorescence ratio of five cells are shown. Bar graphs show peak amplitudes of Ca2+ transients (means ± SEM). (B) WT cells, n = 304; TKO cells, n = 319 from four independent experiments. (C) WT cells, n = 323; TKO cells, n = 296 from four independent experiments. **P < 0.01 (Student’s t test). (D) IP3R1 SCA15/29 mutations analyzed in this study. IP3-binding domain (IP3BD), transmembrane domain (TMD), splice sites (SI, SII, and SIII), and CA-binding site (CA8) are shown. (E) HeLa-TKO cells transfected with mRFP-P2A (mock), mRFP-P2A-IP3R1, or mRFP-P2A-IP3R1 mutants were analyzed by Western blotting with anti-IP3R1.
Fig. 2.
Fig. 2.
IP3-induced Ca2+ release activity of IP3R1 mutants. (A) HeLa-TKO cells transfected with mRFP-P2A (mock), mRFP-P2A-IP3R1, or mRFP-P2A-IP3R1 mutants were loaded with Fura-2 AM and stimulated with 10 μM histamine. Representative traces of Fura-2 fluorescence ratio of five mRFP-positive cells are shown. (B) Peak amplitude of Ca2+ release induced by 10 μM histamine are shown as the mean ± SEM. Number of cells analyzed from at least three independent experiments; WT HeLa, n = 242; TKO cells, mock, n = 108; IP3R1, n = 87; R241K, n = 66; T267M, n = 56; T267R, n = 50; R269G, n = 35; R269W, n = 45; S277I, n = 45; K279E, n = 50; A280D, n = 58; V479I, n = 61; E497K, n = 52; T579I, n = 57; N587D, n = 57; S1478D, n = 50; V1538M, n = 59. (C) Peak amplitude of Ca2+ transients induced by 1 μM thapsigargin are shown as the mean ± SEM. Number of cells analyzed from at least four independent experiments; WT HeLa, n = 146; TKO cells, mock, n = 141; IP3R1, n = 69; R241K, n = 68; T267M, n = 40; T267R, n = 78; R269G, n = 62; R269W, n = 73; S277I, n = 63; K279E, n = 57; A280D, n = 65; V479I, n = 38; E497K, n = 59; T579I, n = 68; N587D, n = 63; S1478D, n = 59; V1538M, n = 44. **P < 0.01 (one-way ANOVA followed by Dunnett’s test, compared with TKO + IP3R1).
Fig. 3.
Fig. 3.
IP3-binding activity of IP3R1 mutants. (A and B) Specific [3H]IP3 binding of GST-IP3R1-(1–589) mutants (A) or GST-IP3R1-(1–700) mutants (B) are shown as the mean ± SD (n = 3). **P < 0.01 (one-way ANOVA followed by Dunnett’s test, compared with WT). (C and D) Crystal structure of mouse IP3R1-(1–2,217) in complex with IP3 (25). Corresponding amino acid numbers in human IP3R1 are shown in parentheses. V494 is in an unsolved region.
Fig. 4.
Fig. 4.
Impacts of S1478D and V1538M mutations on CA8-mediated regulation of IP3R1. (A) HeLa-TKO cells transfected with mRFP-P2A-IP3R1, mRFP-P2A-IP3R1-S1478D, or mRFP-P2A-IP3R1-V1538M were processed for pulldown assay using GST or GST-CA8. Bound proteins were analyzed by Western blotting with anti-IP3R1 or Coomassie Brilliant Blue (CBB) staining. (B) HeLa-TKO cells transfected with mRFP-P2A-IP3R1, mRFP-P2A-IP3R1-S1478D, or mRFP-P2A-IP3R1-V1538M with or without HA-CA8 were processed for immunoprecipitation with anti-HA antibody. Immunoprecipitates were analyzed by Western blotting with anti-IP3R1 and anti-HA. (C) 2/3 DKO (Top), 1/3 DKO (Middle), or 1/2 DKO (Bottom) HeLa cells were transfected with mRFP-P2A or mRFP-P2A-CA8. Cells were loaded with Fura-2 AM and stimulated with 5 μM histamine. Representative traces of Fura-2 fluorescence ratio of mRFP-positive cells are shown. Bar graphs show the peak amplitude of Ca2+ release represented as the mean ± SEM. Number of cells analyzed from four independent experiments; 2/3 DKO, mock, n = 165, CA8, n = 171; 1/3 DKO, mock, n = 193, CA8, n = 186; 1/2 DKO, mock, n = 176, CA8, n = 189. (D) HeLa-TKO cells were transfected with mRFP-P2A-IP3R1 (Top), mRFP-P2A-IP3R1-S1478D (Middle), or mRFP-P2A-IP3R1-V1538M (Bottom) with mock or HA-CA8 (plasmid ratio 1:3). Cells were processed for Ca2+ imaging as described in C. Number of cells analyzed from seven independent experiments; IP3R1 + mock, n = 56; IP3R1 + CA8, n = 71; S1478D + mock, n = 56; S1478D + CA8, n = 67; V1538M + mock, n = 68; V1538M + CA8, n = 76. **P < 0.01 (Student’s t test).
Fig. 5.
Fig. 5.
Impacts of CA8 mutations on the regulation of IP3R1. (A) HeLa cells transfected with mRFP-P2A-CA8, mRFP-P2A-CA8-S100P, or mRFP-P2A-CA8-G162R were treated with 50 μg/mL cycloheximide (CHX) for 0, 4, or 8 h. Expression levels of CA8 were analyzed by Western blotting with anti-CA8. Band intensities were represented as the mean ± SD (n = 3). (B) HeLa cell lysates were processed for pulldown assay using GST, GST-CA8, GST-CA8-S100P, or GST-CA8-G162R. Bound proteins were analyzed by Western blotting with anti-IP3R1 or CBB staining. (C) HeLa cells transfected with mock, HA-CA8, HA-CA8-S100P, or HA-CA8-G162R were processed for immunoprecipitation with anti-HA antibody. Immunoprecipitates were analyzed by Western blotting with anti-IP3R1 and anti-HA. (D) The 2/3 DKO HeLa cells were transfected with mRFP-P2A, mRFP-P2A-CA8, mRFP-P2A-CA8-S100P, or mRFP-P2A-CA8-G162R. Cells were loaded with Fura-2 AM and stimulated with 5 μM histamine. Representative traces of Fura-2 fluorescence ratio of mRFP-positive cells are shown. Bar graph shows peak amplitude of Ca2+ release represented as the mean ± SEM. Number of cells analyzed from four independent experiments; mock, n = 146, CA8, n = 128; CA8-S100P, n = 157, CA8-G162R, n = 151. **P < 0.01 (one-way ANOVA followed by Tukey–Kramer test).

References

    1. Matilla-Dueñas A, et al. Consensus paper: Pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum. 2014;13:269–302. - PMC - PubMed
    1. Zambonin JL, et al. Care4Rare Canada Consortium Spinocerebellar ataxia type 29 due to mutations in ITPR1: A case series and review of this emerging congenital ataxia. Orphanet J Rare Dis. 2017;12:121. - PMC - PubMed
    1. Huang L, et al. Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia. Orphanet J Rare Dis. 2012;7:67. - PMC - PubMed
    1. Ohba C, et al. Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood. Neurogenetics. 2013;14:225–232. - PubMed
    1. Fogel BL, et al. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol. 2014;71:1237–1246. - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts